Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 29th International Papillomavirus Conference (HPV 2014)
Dramatic Reductions in Cervical Cancer Possible with New 9-valent HPV Vaccine
Seattle, Washington / August 21-25, 2014
Seattle - Worldwide, the human papilloma virus (HPV) causes over 600,000 cases of cancer in men and women every year, cervical cancer by far and away being the most common. Prevention of approximately 70% of all cervical cancer is now...
MEDI-NEWS - Based on Government of Ontario Immunization of School Pupils Act
Immunization of School Pupils: What Ontario Physicians Should Know
July 2014
The Ontario government has recently modified immunization requirements for school-age children, mandating receipt of the meningococcal, pertussis and varicella vaccines for school entry. The clinical implications of these new requirements...
PRIORITY PRESS - 70th Annual Clinical and Scientific Conference of the Society of Obstetricians and Gynecologists of Canada (SOGC)
Update on HPV: Primary Care Providers Gatekeepers of Sexual Health for Mid-Life Women
Niagara Falls, Ontario / June 10-13, 2014
Niagara Falls, Ontario - Human papilloma virus (HPV) vaccines have been widely accepted as a primary prevention strategy in children and adolescents prior to their sexual debut before they are exposed to HPV. Less well accepted is the need...
MEDI-NEWS - Based on Guidelines Prepared by the Meningococcal B Pilot Project Task Group
Young Infants and the Multi-Component Serogroup B Vaccine: New NACI Recommendations for Healthcare Professionals
March 26, 2014
Invasive meningococcal disease (IMD) is an acute and serious infection caused by the bacterium Neisseria meningitidis. In Canada, 5 serogroups are responsible for IMD, of which serogroup B is now the most prevalent, especially among infants...
MEDI-NEWS - Based on Van Buynder et al. Vaccine Published ahead of print August 6, 2013; Scheifele et al. Human Vaccines & Immunotherapeutics 2013;9:11:1-14.
Influenza Vaccination in Older Populations: Adjuvanted vs Non-Adjuvanted Vaccine Comparisons
November 2013
Immunosenescence that occurs as a result of normal aging impairs response to any vaccine including influenza vaccines. By adding an adjuvant, an adjuvanted trivalent inactive influenza vaccine (aTIV) has the potential to invoke more robust...
MEDI-NEWS - Based on PLOS ONE. November 2012, Volume 7, Issue 11.
Invasive Meningococcal Disease Epidemiology in Quebec: Changes Demand New Vaccination Strategies against Dominant Strains
October 2013
Significant changes in the epidemiology of invasive meningococcal disease (IMD) have been observed in the province of Quebec during the last two decades. As in many other developed countries, most IMD in Quebec was once caused by serogroup...
MEDI-NEWS - Based on Lancet 2013;381(9869):825-35.
Invasive Meningococcal Disease in Infants: Immunogenicity and Safety of a Novel Multi-Component Serogroup B Vaccine
Serogroup B is now the dominant cause of invasive meningococcal disease (IMD) in Canada where it disproportionally affects infants. This underscores the importance of having an effective vaccine for this vulnerable age group. A...
PRIORITY PRESS - AMMI Canada - CACMID Annual Conference
New NACI Guidelines for Pneumococcal Disease Prevention in High-Risk Adults
Québec City, Quebec/ April 4-6, 2013
Québec City - Prevention of pneumococcal and other vaccine-preventable diseases is challenging in patients with immune deficiency. Vaccines are less immunogenic in this population. Many patients have not had recommended...
MEDI-NEWS - Update on Quadrivalent Conjugate Meningococcal Vaccines
From the National Advisory Committee on Immunization
March 2013
Ottawa - An update from the National Advisory Committee on Immunization (NACI) on quadrivalent conjugate meningococcal vaccines now includes recommendations for the use of the most recent of these vaccines, MenACWY-CRM197 and provides a...